TiumBio Receives Approval for Phase 2a Clinical Trial Plan of Endometriosis Treatment

[Asia Economy Reporter Minji Lee] Tium Bio announced on the 24th that it has received approval for the Phase 2a clinical trial plan of the endometriosis treatment TU2670 in Ukraine.

The company stated, "The Phase 2a clinical trial of TU2670 will be conducted in multiple European countries (Ukraine, Russia, Italy, Poland, Czech Republic) to improve patient enrollment rates," and added, "We plan to disclose the clinical trial plan applications for Italy, Poland, and the Czech Republic in accordance with disclosure guidelines in the future."